Early monitoring of patients and point of care testing provide timely results that support healthcare professionals in treatment decision making.

High-quality products and patient safety are the core of our business. We specialize in point of care and our product portfolio provides solutions among others for infectious disease diagnostics, improved management of diabetes, and colorectal cancer screening. In addition, we provide easy to use products for hygiene monitoring for the use of hospitals and industries.

In healthcare, proper use of antibiotics is key in prevention of antimicrobial resistance (AMR), one of the biggest threats to global health. Testing before prescribing using fast and accurate point of care tests guides rational antibiotic prescribing. C-reactive protein (CRP) is an excellent tool to increase diagnostic certainty and guide correct use of antibiotics. Our products provide solutions to fight against AMR and drive sustainable use of antibiotics in primary care.

Our global footprint covers over 60 countries. Our QuikRead go® flagship products are used globally, with over 60,000 instruments in use by our customers. We are fully compliant with the ISO 13485 Quality Standard as well as FDA requirements.

We have approximately 300 dedicated employees who want to be in the forefront of creating tools for better healthcare. In addition to our Head Quarters in Espoo, Finland, we have local offices in 12 different countries: Sweden, Norway, Denmark, Germany, Czech Republic, Slovakia, Hungary, Poland, the Netherlands, Belgium, Estonia, and China.

Aidian, formerly Orion Diagnostica, is a Finnish-based in vitro diagnostics (IVD) company established in 1974. We develop, manufacture, and distribute reliable and fast CE marked diagnostic tests especially for primary care. Our aim is to aid health globally by promoting efficient healthcare through accurate and fast diagnostics. For achieving this we want to provide innovative solutions for point of care. Early monitoring of patients and point of care testing provide timely results that support healthcare professionals in treatment decision making.

High-quality products and patient safety are the core of our business. We specialize in point of care and our product portfolio provides solutions among others for infectious disease diagnostics, improved management of diabetes, and colorectal cancer screening. In addition, we provide easy to use products for hygiene monitoring for the use of hospitals and industries.

In healthcare, proper use of antibiotics is key in prevention of antimicrobial resistance (AMR), one of the biggest threats to global health. Testing before prescribing using fast and accurate point of care tests guides rational antibiotic prescribing. C-reactive protein (CRP) is an excellent tool to increase diagnostic certainty and guide correct use of antibiotics. Our products provide solutions to fight against AMR and drive sustainable use of antibiotics in primary care.

Our global footprint covers over 60 countries. Our QuikRead go® flagship products are used globally, with over 60,000 instruments in use by our customers. We are fully compliant with the ISO 13485 Quality Standard as well as FDA requirements.

We have approximately 300 dedicated employees who want to be in the forefront of creating tools for better healthcare. In addition to our Head Quarters in Espoo, Finland, we have local offices in 12 different countries: Sweden, Norway, Denmark, Germany, Czech Republic, Slovakia, Hungary, Poland, the Netherlands, Belgium, Estonia, and China.

Mission and vision

Mission

To be the best partner for our customers by using our knowhow to offer cost-effective and smart solutions for primary care.
Vision

Aid health globally by promoting efficient and fluent healthcare.

Uricult Vet Test - Marketing and Sales Materials